ClinicalTrials.Veeva

Menu

Myofascial Therapy in Patients With Hemophilic Arthropathy (He-Fascial)

U

Universidad Católica San Antonio de Murcia

Status

Unknown

Conditions

Hemophilia

Treatments

Other: Myofascial therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02433782
He-Fascial

Details and patient eligibility

About

Designing a treatment protocol using myofascial therapy for the treatment of pain and restrictions on mobility in patients with hemophilic arthropathy of the knee and ankle.

Pilot with a small number of patients for assessment the effectiveness and safety of the treatment protocol created.

Randomized clinical trial to assess the effectiveness of treatment with myofascial therapy in patients with hemophilia.

Describe the differences in terms of the dependent variables (range of motion, pain and flexibility) in patients with hemophilia who have carried out the treatment.

Report the relationship between the clinical characteristics of patients and the results obtained after the treatment period.

Full description

Phase I pilot study with 5 patients with hemophilia for assessment by myofascial therapy protocol designed for this purpose.

Phase II. Randomized, prospective longitudinal clinical study in patients with hemophilia, to assess the efficacy of an intervention with myofascial therapy.

Enrollment

25 estimated patients

Sex

Male

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with a diagnosis of hemophilia A and B.
  • Patients older than 18 years.
  • Patients with a diagnosis of hemophilic arthropathy of the knee and ankle.
  • Patients on prophylactic regimen with FVIII / FIX.

Exclusion criteria

  • Patients without walking ability.
  • Patients with a diagnosis of other congenital coagulopathy (eg von Willebrand disease).
  • Patients who have developed antibodies to FVIII / FIX (inhibitors).
  • Patients with neurological or cognitive impairments that impede understanding of questionnaires and physical test.
  • Patients who have not signed the informed consent document.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

25 participants in 2 patient groups

Experimental group
Experimental group
Description:
Treatment through myofascial therapy for the treatment of pain and restricted mobility in patients with hemophilic arthropathy of the knee and ankle
Treatment:
Other: Myofascial therapy
Control group
No Intervention group
Description:
No myofascial intervention. Patients continue their treatment with FVIII or FIX concentrates, normally

Trial contacts and locations

1

Loading...

Central trial contact

RUBEN CUESTA-BARRIUSO, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems